Comparison between Radioiodine Therapeutic and Diagnostic Whole Body Scans in Postoperative Differentiated Thyroid Carcinoma Patients Correlation with Serum Thyroglobulin Levels

Abstract

It has been reported that distant metastases are the main cause of death in patients with thyroid carcinoma [1,2]. The whole body I-131 scan has been reported to be an efficient tool to follow up thyroid carcinoma [3]. Posttherapeutic and diagnostic scans can be used to evaluate the presence of recurrent thyroid cancer or the presence of thyroid distant metastases. However, a higher image quality or better detection of additional lesions can be achieved in the therapeutic scan by a delayed imaging of 4-7 days [4,5]. Additional lesions could be seen in immediate posttherapeutic dose [6]. Minimizing the risk of recurrence and metastases can be achieved in patients with differentiated thyroid cancer undergoing high-dose I-131 [1,6]. Comparison between radioiodine therapeutic and diagnostic whole body scans in postoperative differentiated thyroid carcinoma patients : correlation with serum thyroglobulin levels. J Med Liban 2017 ; 65 (1) : 25-28.Al-Shammeri I, Mahmood S, Al-Mohannadi S, Ballani N. Comparaison entre la radioiodine thérapeutique et les scans corporels de diagnostic chez des patients souffrant d'un carcinome thyroïdien différencié en postopératoire : corrélation avec les taux sériques de thyroglobuline. J Med Liban 2017 ; 65 (1) : 25-28.